Literature DB >> 31554702

The genetics of interstitial lung diseases.

Raphael Borie1,2, Pierre Le Guen1,2, Mada Ghanem1,2, Camille Taillé1,2, Clairelyne Dupin1,2, Philippe Dieudé2,3, Caroline Kannengiesser2,4, Bruno Crestani5,2.   

Abstract

Interstitial lung diseases (ILDs) are a set of heterogeneous lung diseases characterised by inflammation and, in some cases, fibrosis. These lung conditions lead to dyspnoea, cough, abnormalities in gas exchange, restrictive physiology (characterised by decreased lung volumes), hypoxaemia and, if progressive, respiratory failure. In some cases, ILDs can be caused by systemic diseases or environmental exposures. The ability to treat or cure these ILDs varies based on the subtype and in many cases lung transplantation remains the only curative therapy. There is a growing body of evidence that both common and rare genetic variants contribute to the development and clinical manifestation of many of the ILDs. Here, we review the current understanding of genetic risk and ILD.
Copyright ©ERS 2019.

Entities:  

Mesh:

Year:  2019        PMID: 31554702     DOI: 10.1183/16000617.0053-2019

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  8 in total

Review 1.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

2.  Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease.

Authors:  Sara Remuzgo-Martínez; Fernanda Genre; Verónica Pulito-Cueto; Belén Atienza-Mateo; Víctor Manuel Mora Cuesta; David Iturbe Fernández; Sonia María Fernández Rozas; Leticia Lera-Gómez; Pilar Alonso Lecue; María Piedad Ussetti; Rosalía Laporta; Cristina Berastegui; Amparo Solé; Virginia Pérez; Alicia De Pablo Gafas; Oreste Gualillo; José Manuel Cifrián; Raquel López-Mejías; Miguel Ángel González-Gay
Journal:  Biomedicines       Date:  2021-04-22

3.  Clustering of lung diseases in the family of interstitial lung disease patients.

Authors:  Michelle Terwiel; Jan C Grutters; Coline H M van Moorsel
Journal:  BMC Pulm Med       Date:  2022-04-07       Impact factor: 3.317

4.  Turkish Thoracic Society Early Career Members Task Force Group's Virtual Congress Notes: European Respiratory Society International Congress 2020.

Authors:  Deniz Kızılırmak; Dilek Karadoğan; Halime Yıldırım; Fatma Tokgöz Akyıl; Tuğba Şişmanlar Eyüboğlu; Nagehan Emiralioğlu; Ümran Özden Sertçelik; Fatma Esra Günaydın; Özlem Ataoğlu; Merve Sinem Oğuz; Selin Çakmakcı; Neslihan Özçelik; Aslı Öncel; Ali Fırıncıoğluları; Bilge Yılmaz Kara; Dilara Ömer; Selen Karaoğlanoğlu; Nazli Cetin; Fatma Gulsum Karakas; Canan Gunduz Gurkan; Feride Marim; Tuğba Önyılmaz; Demet Polat Yuluğ; Nilufer Aylin Acet Öztürk; Özge Aydın Güçlü; Tuba Çiftçi Küsbeci; İrem Şerifoğlu; Hüseyin Arıkan; Zehra Nur Töreyin; Pınar Çelik; Metin Akgün
Journal:  Turk Thorac J       Date:  2022-03

Review 5.  Histopathology and genetic susceptibility in COVID-19 pneumonia.

Authors:  Jan von der Thüsen; Menno van der Eerden
Journal:  Eur J Clin Invest       Date:  2020-06-27       Impact factor: 5.722

6.  Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.

Authors:  Sung Kyoung Kim; Seung Min Jung; Kyung-Su Park; Ki-Jo Kim
Journal:  BMC Pulm Med       Date:  2021-12-07       Impact factor: 3.317

7.  Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases.

Authors:  Matthias Griese
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

Review 8.  Telomeres in Interstitial Lung Disease.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.